BioNTech to Showcase Oncology Late-Stage Pipeline Progress and Pumitamig Novel-Novel Combination Data at ESMO 2026
Go back to BioNTech to Showcase Oncology Late-Stage Pipeline Progress and Pumitamig Novel-Novel Combination Data at ESMO 2026| (NASDAQ: BNTX) | Delayed: 91.29 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $91.29 | 52 Week High | $ | |||
| Open | $91.29 | 52 Week Low | $ | |||
| Day High | $91.29 | P/E | N/A | |||
| Day Low | $91.29 | EPS | $ | |||
| Volume | 3,695 | |||||



